483 Octapharma AB Jan 2012

483 Octapharma AB Jan 2012

Jacqueline Diaz Albert FDA, Susan Jackson FDA$119.00 - Available Now

FDA investigators audited the Octapharma AB - Stockholm, Sweden facility and issued inspectional observations (via FDA 483) on 19 Jan 2012.

Product details

  • Category: Biologics
  • Inspection end: 19 Jan 2012
  • Location: Stockholm, Sweden
  • FEI: 3005559915
Add To Cart